Association between circular RNA expression content and severity of coronary atherosclerosis in human coronary artery. Issue 12 (5th September 2020)

• Record Type: Journal Article
• Authors: Hou, Can; Gu, Lingfeng; Guo, Yi; Zhou, Yaqing; Hua, Lei; Chen, Jiaxin; He, Shu; Zhang, Sheng; Jia, Qiaowei; Zhao, Chenhui; Zhang, Jing; Xu, Guangxu; Jia, Enzhi
• Is Part Of: Journal of clinical laboratory analysis. Volume 34:Issue 12(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-09-05
• Subjects: CircRNAs -- coronary artery samples -- coronary heart disease -- qRT‐PCR; Diagnosis, Laboratory -- Periodicals; Medical laboratory technology -- Periodicals; 616
• DOI: 10.1002/jcla.23552
• Languages: English
• ISSNs: 0887-8013

Abstract

Abstract: Background: Circular RNAs (circRNAs) may act as biomarkers of coronary artery disease (CAD). However, the relationship between expression characteristics of circRNAs and coronary atherosclerosis has not been fully explored. The aim of this study was to determine and characterize the circRNAs from human coronary artery. Methods: The coronary artery segments were obtained from an 81‐year‐old male patient with sudden death of myocardial infarction at autopsy. The coronary stenosis and atherosclerosis were evaluated by hematoxylin and eosin (H&E) staining, and the circRNAs expression profile was characterized by RNA sequencing (RNA‐seq). The differentially expressed circRNAs were validated by qRT‐PCR. Results: The analysis of H&E staining indicated that coronary atherosclerosis grade and extent in the LM was more serious than that in other coronary arteries. Twenty‐seven circRNAs were selected for expression validation in coronary artery. CircRNAs corresponding cyclization sites of 3 circRNAs (hsa_circ_0016868, hsa_circ_0001364, hsa_circ_0006731) have been verified by Sanger sequencing. Conclusion: The 3 circRNAs are suggested to play a pathological role underlying the coronary arteries atherosclerosis and may serve as a valuable resource as diagnostic or therapeutic targets against CAD. Abstract : The overall technology roadmap of the present study (A) Coronary artery samples preparation (B) RNA‐Seq library preparation, and sequencing (C) qRT‐PCR forward and reverse prime (D) Sanger sequencing samples preparation, and steps